Next Article in Journal
Fractionation of Whey Protein Isolate with Supercritical Carbon Dioxide—Process Modeling and Cost Estimation
Next Article in Special Issue
Molecular Diagnostic and Pathogenesis of Hereditary Hemochromatosis
Previous Article in Journal
Vinculin Motion Modes Analysis with Elastic Network Model
Previous Article in Special Issue
Genetic Variability and Phylogeny of High Risk HPV Type 16, 18, 31, 33 and 45 L1 Gene in Greek Women
Int. J. Mol. Sci. 2012, 13(1), 221-239; doi:10.3390/ijms13010221

Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms

 and *
Received: 10 October 2011 / Revised: 29 November 2011 / Accepted: 20 December 2011 / Published: 27 December 2011
(This article belongs to the Special Issue Advances in Molecular Diagnostics)
View Full-Text   |   Download PDF [341 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Medullary thyroid carcinoma is a rare malignant tumor originating in parafollicular C cells. It accounts for 5 to 8% of all thyroid cancers. MTC develops in either sporadic (75%) or hereditary form (25%). Genetic and molecular studies have demonstrated the involvement of the RET proto-oncogene in hereditary MTC and, less often, in its sporadic form. Although a strong genotype-phenotype correlation has been described, wide clinical heterogeneity is observed among families with the same RET mutation or even in carriers of the same kindred. In recent years, several single nucleotide polymorphisms of the RET gene have been described in the general population as well as in patients with MTC. Some studies have reported associations between the presence of polymorphisms and development or progression of MTC. Nonetheless, other studies failed to demonstrate any effect of the RET variants. Differences in the genetic background of distinct populations or methodological approaches have been suggested as potential reasons for the conflicting results. Here, we review current knowledge concerning the molecular pathogenesis of sporadic and hereditary MTC. In particular, we analyze the role of RET polymorphisms in the clinical presentation and prognosis of MTC based on the current literature.
Keywords: medullary thyroid carcinoma; RET polymorphisms; prognosis medullary thyroid carcinoma; RET polymorphisms; prognosis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Ceolin, L.; Siqueira, D.R.; Romitti, M.; Ferreira, C.V.; Maia, A.L. Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms. Int. J. Mol. Sci. 2012, 13, 221-239.

AMA Style

Ceolin L, Siqueira DR, Romitti M, Ferreira CV, Maia AL. Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms. International Journal of Molecular Sciences. 2012; 13(1):221-239.

Chicago/Turabian Style

Ceolin, Lucieli; Siqueira, Débora R.; Romitti, Mírian; Ferreira, Carla V.; Maia, Ana Luiza. 2012. "Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms." Int. J. Mol. Sci. 13, no. 1: 221-239.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert